Emmessar Biotech & Nutrition share news and announcements
BSE: 524768Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹22.32.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹11 Cr4,463rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 31 Aug 2026
- 26.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 1.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 31 Aug 2026
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 31 Aug 2026
- −18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 5,899
Emmessar Biotech & Nutrition share news and announcements
536 announcements, routine notices left out, newest first. Page 4 of 11.
Apr 2022
12 Apr · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on April 12, 2022 with reference to significant movement in price, in order to ensure that investors have latest ....12 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 011 Apr · Compliance Certificate Under Regulation 7(3) Of SEBI [LODR] Regulations, 2015, For The Year Ended March 31, 2022.
7 Apr · Cert. U/R 40(9) Of SEBI [Listing Obligations And Disclosure Requirements] Regulation, 2015 For The Year Ended March 31, 2022.
Mar 2022
23 Mar · Announcement Under Regulation 30 (LODR) Updates - Communication To Physical Shareholders.
Feb 2022
2 Feb · Board meeting
Meeting on 11 Feb 2022: quarterly results
Jan 2022
13 Jan · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on January 13, 2022 with reference to significant movement in price, in order to ensure that investors have latest ....8 Jan · Shareholding for the Period Ended December 31, 2021
Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....7 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Oct 2021
11 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 011 Oct · Board meeting
Meeting on 20 Oct 2021: quarterly results7 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....4 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Sep 2021
Aug 2021
Jul 2021
19 Jul · Board meeting
Meeting on 29 Jul 2021: quarterly results16 Jul · Shareholding for the Period Ended June 30, 2021
Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....14 Jul · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on July 14, 2021 with reference to significant movement in price, in order to ensure that investors have latest ....8 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2021
1 Jun · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on June 1, 2021 with reference to significant movement in price, in order to ensure that investors have latest ....
May 2021
31 May · Disclosure Of Related Party Transactions
12 May · Board meeting
Meeting on 21 May 2021: audited results
Apr 2021
28 Apr · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on April 28, 2021 with reference to significant movement in price, in order to ensure that investors have latest ....12 Apr · Shareholding for the Period Ended March 31, 2021
Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....8 Apr · Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 08 Apr · Compliance Under Regulation 40(9) Of SEBI [LODR]
5 Apr · Compliance Certificate For The Period October 01, 2020 To March 31, 2021
Feb 2021